Summary & Overview
CPT 64616: Unilateral Cervical Muscle Chemical Denervation
CPT code 64616 denotes a targeted chemical denervation procedure performed on unilateral neck muscles with avoidance of the laryngeal muscles to induce muscle paralysis. Clinically, it is used to treat conditions such as cervical dystonia and spasmodic torticollis, which produce sustained, often painful neck muscle contractions and abnormal head posture. The code matters nationally because these procedures affect neurologic and musculoskeletal specialty care pathways and have implications for outpatient surgical capacity and medical necessity determinations.
Key payers covered in this analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise overview of clinical indications tied to the code, the typical ambulatory settings in which the service is delivered, and commonly observed billing considerations. The publication also summarizes payer coverage patterns and benchmark perspectives where available, highlights relevant policy and coding updates that impact authorization and documentation requirements, and situates CPT code 64616 within clinical care workflows for movement disorder management.
Data not available in the input is noted where applicable.
Billing Code Overview
CPT code 64616 describes a targeted chemical denervation procedure in which a provider injects a neurolytic or neuromodulatory chemical agent into unilateral neck muscles while avoiding the laryngeal muscles. The procedure is intended to produce paralysis of the treated muscles to reduce sustained or painful involuntary contractions.
-
Service type: Outpatient targeted chemical denervation/therapeutic injection to cervical muscles
-
Typical site of service: Ambulatory surgical center or office-based outpatient procedure room
Clinical & Coding Specifications
Clinical Context
A 48-year-old patient presents to a neurology clinic with a 6-month history of involuntary, sustained neck muscle contractions causing the head to twist to the right and intermittent neck pain and functional impairment. Examination demonstrates focal hypertrophy and palpable spasm of the right sternocleidomastoid and splenius capitis muscles consistent with cervical dystonia (spasmodic torticollis). The clinician documents baseline pain scores, functional limitation, prior conservative therapy (physical therapy, oral medications), and informed consent. The procedure involves administration of a botulinum toxin preparation into selected unilateral cervical muscles while avoiding laryngeal muscle injection sites. Typical workflow: pre-procedure consent and timeout, localization of target muscles by palpation and optional electromyography (EMG) or ultrasound guidance, aseptic preparation, injection of botulinum toxin in measured units into identified muscles, monitoring for immediate adverse effects, and discharge with post-procedure instructions and a follow-up plan. Typical site of service is an outpatient specialty clinic or ambulatory surgical center. Documentation includes indication, targeted muscles and laterality, toxin type and units, guidance method (if used), complications or adverse events, and planned follow-up.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
26 | Professional component | When reporting only the professional interpretation or service component if a separate technical component is billed by another provider or facility. |